NeonMind Biosciences Inc. (NMDBF) Research

NeonMind Biosciences Inc. specializes in the research, formulation, and commercialization of medicinal and psychedelic fungi aimed at treating mental health conditions. The company is actively developing a line of psilocybin-derived products, featuring various mushroom-infused preparations, specifically tailored for weight loss and management. Originally incorporated in 2019 as Flourish Mushroom Labs Inc., it rebranded to NeonMind Biosciences Inc. in April 2020. Headquartered in Oakville, Canada, the company operates as a subsidiary of The Yield Growth Corp.

Market snapshot

Symbol
NMDBF
Price
$0.01
Day change
0.00%
Market cap
$11.0K
P/E ratio
-0.01x
52-week range
0.0041-0.228
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Gene Biotherapeutics, Inc. (CRXM)
  • E-Qure Corp. (EQUR)
  • Gelesis Holdings, Inc. (GLSHQ)
  • Generex Biotechnology Corporation (GNBT)
  • GeneThera, Inc. (GTHR)
  • EastWest Bioscience Inc. (HBOSF)
  • MobileSmith, Inc. (MOSTQ)
  • Navidea Biopharmaceuticals, Inc. (NAVB)

Open NeonMind Biosciences Inc. (NMDBF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.